COVID-19 pandemic
AstraZeneca is expected to resume vaccine trials in the United States as early as this week.
Sources: CNBC
Changes
- AstraZeneca is expected to resume vaccine trails in the United States as early as this week.
- AstraZeneca is expected to resume vaccine trials in the United States as early as this week.
Related
Supreme Leader Ali Khamenei calls for a ban on the American Pfizer and British AstraZeneca vaccines.
A record 185,759 new cases are reported in the United States, according to Johns Hopkins University.